We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Loss of Gene Found to Accelerate Aging

By Biotechdaily staff writers
Posted on 31 Aug 2005
Scientists have found that the loss of a gene called p63 accelerates aging in mice, according to new research. More...
Similar versions of the gene are present in many organisms, including humans. Therefore, the p63 gene probably plays an essential biologic role in aging-related processes.

"To study how the p63 gene works, we devised a system for eliminating it from adult mouse tissues. What struck us right away was that these p63-deficient mice were aging prematurely,” commented Dr. Alea Mills of Cold Spring Harbor Laboratory (NY, USA), who led the study.

Mice born without the p63 gene do not survive. Therefore, the researchers had earlier performed extensive studies of mice that are born with only one copy of the gene, which demonstrated that these mice die at a young age. Therefore, to assess p63 function in adults, Dr. Mills and coworkers created an advanced molecular genetic method that enabled them to eliminate both copies of the gene from specific tissues--including skin and other multi-layered epithelial tissues--after the mice reached maturity.

The effects of premature aging seen in these p63-deficient mice were reduced fitness and body weight, hair loss, progressive curvature of the spine, and a shortened lifespan. "Aging and cancer are two sides of the same coin. In one case, cells stop dividing and in the other, they can't stop dividing. We suspect that having the right amount of the p63 protein in the right cells at the right time creates a balance that enables organisms to live relatively cancer-free for a reasonably long time,” stated Dr. Mills, who added that this is the first time the p63 gene has been implicated in aging. "I first presented these results at a meeting in Tuscany [Italy]. I don't want to sound flippant, but if you have to grow old somewhere, that's about as good a place as any to do it.”

The study was published in the September 2005 issue of the journal Genes & Development.





Related Links:
Cold Spring Harbor Laboratory

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.